I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The real-life efficacy and safety of osimertinib in pretrea..:
Güven, Deniz Can
;
Caner, Burcu
;
Can, Alper
...
Journal of Cancer Research and Clinical Oncology. , 2022
Link:
https://hdl.handle.net/11499/47357
RT Journal T1
The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study
UL https://suche.suub.uni-bremen.de/peid=base-ftpamukkaleuniv:oai:gcris.pau.edu.tr:11499_47357&Exemplar=1&LAN=DE A1 Güven, Deniz Can A1 Caner, Burcu A1 Can, Alper A1 Gülmez, Ahmet A1 Hizal M A1 Bilgin B A1 Paksoy N A1 Açıkgöz Ö A1 Sezer A A1 Gürbüz M A1 Ak N A1 Yücel, Şebnem A1 Ayhan, Murat A1 Erol, Cihan A1 Demirkıran, Aykut A1 Mandel, Nil Molinas A1 Shbair, Abdallah A1 Gökmen, İvo A1 Başoğlu, Tuğba A1 Zeynelgil, Esra A1 Tatlı, Ali Murat A1 Demirkazık, Ahmet A1 Yumuk, Perran Fulden A1 Demiray, Atike Gökçen A1 İriağaç, Yakup A1 Şakalar, Teoman A1 Bahçeci, Aykut A1 Karakaş, Yusuf A1 Yalçın, Bülent A1 Bilici, Ahmet A1 Aydıner, Adnan A1 Şendur, Mehmet Ali Nahit A1 Paydaş, Semra PB Springer Science and Business Media Deutschland GmbH YR 2022 K1 EGFR K1 Non-small cell lung cancer K1 Osimertinib K1 Second line K1 T790M K1 afatinib K1 circulating tumor DNA K1 epidermal growth factor receptor K1 erlotinib K1 gefitinib K1 protein K1 t790m protein K1 unclassified drug K1 acrylamide derivative K1 aniline derivative K1 protein kinase inhibitor K1 adult K1 advanced cancer K1 adverse drug reaction K1 Article K1 brain metastasis K1 cancer patient K1 cancer survival K1 clinical feature K1 controlled study K1 decreased appetite K1 diarrhea K1 drug efficacy K1 drug safety K1 exon K1 fatigue K1 female K1 follow up K1 gene mutation K1 human K1 major clinical study K1 male K1 multicenter study K1 non small cell lung cancer K1 overall survival K1 pneumonia K1 retrospective study K1 skin toxicity K1 time to treatment K1 treatment response K1 treatment withdrawal K1 clinical trial JF Journal of Cancer Research and Clinical Oncology LK http://dx.doi.org/https://hdl.handle.net/11499/47357 DO https://hdl.handle.net/11499/47357 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)